Although the authors of this study conclude that NF-KB, and not the NRF2 pathway, is responsible for the observed phenotype, it might be worth studying the miR-141/KEAP1/NRF2 axis due to the known role of NRF2 in promoting cisplatin resistance in other tumor types. This evidence concerns the gene NFE2L2 and neoplasm.